{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:31:01Z","timestamp":1787153461579,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.beem.2025.102067","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:09:01Z","timestamp":1762416541000},"page":"102067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of chronic hyponatremia and controversy about osmotic demyelination syndrome"],"prefix":"10.1016","volume":"40","author":[{"given":"Julia","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2025.102067_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archneurpsyc.1959.02340140020004","article-title":"Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients","volume":"81","author":"Adams","year":"1959","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"10.1016\/j.beem.2025.102067_bib2","article-title":"Primary polydipsia: update","volume":"34","author":"Ahmadi","year":"2020","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102067_bib3","doi-asserted-by":"crossref","DOI":"10.34067\/KID.0000000830","article-title":"Plasma sodium correction rates in patients with severe hyponatremia treated with hypertonic saline with and without proactive desmopressin","volume":"6","author":"AlShanableh","year":"2025","journal-title":"Kidney360"},{"key":"10.1016\/j.beem.2025.102067_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2300014","article-title":"Hyponatremia treatment guidelines \u2014 have they gone too far?","volume":"2","author":"Ayus","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.beem.2025.102067_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jamainternmed.2024.5981","article-title":"Correction rates and clinical outcomes in hospitalized adults with severe hyponatremia: a systematic review and meta-analysis","volume":"185","author":"Ayus","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.beem.2025.102067_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ejendo\/lvaf115","article-title":"Severe symptomatic hyponatremia in Europe: Insights into current clinical practice","volume":"192","author":"Beck","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.102067_bib7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ki.1990.78","article-title":"Treating hyponatremia: damned if we do and damned if we don\u2019t","volume":"37","author":"Berl","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2025.102067_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6030028","article-title":"Long-term Vaptan treatment of idiopathic SIADH in an octogenarian","volume":"6","author":"B\u00fcttner","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.beem.2025.102067_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0167-5273(87)90040-4","article-title":"Urea treatment for water retention in hyponatremic congestive heart failure","volume":"17","author":"Cauchie","year":"1987","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.beem.2025.102067_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.ajkd.2024.07.011","article-title":"Urea to treat hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion: a systematic review and meta-analysis","volume":"85","author":"Chander","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2025.102067_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00271","article-title":"Empagliflozin contributes to polyuria via regulation of sodium transporters and water channels in diabetic rat kidneys","volume":"10","author":"Chung","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.beem.2025.102067_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9343(01)00678-7","article-title":"Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide","volume":"110","author":"Decaux","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2025.102067_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9629(15)40736-0","article-title":"The urine\/plasma electrolyte ratio: a predictive guide to water restriction","volume":"319","author":"Furst","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.beem.2025.102067_bib14","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa619","article-title":"Fluid restriction therapy for chronic SIAD; results of a prospective randomized controlled trial","volume":"105","author":"Garrahy","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102067_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2015.4","article-title":"Current treatment practice and outcomes. Report of the hyponatremia registry","volume":"88","author":"Greenberg","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2025.102067_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/dom.13126","article-title":"Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis","volume":"20","author":"Hallow","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.beem.2025.102067_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/ckj\/sfw034","article-title":"The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients","volume":"9","author":"Hanna","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.beem.2025.102067_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-78-6-870","article-title":"Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. an alternative treatment to hypertonic saline","volume":"78","author":"Hantman","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2025.102067_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuint.2009.02.020","article-title":"Astrocytes are a major target in thiamine deficiency and Wernicke\u2019s encephalopathy","volume":"55","author":"Hazell","year":"2009","journal-title":"Neurochem Int"},{"key":"10.1016\/j.beem.2025.102067_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.ajkd.2019.11.012","article-title":"Efficacy of furosemide, oral sodium chloride, and fluid restriction for treatment of syndrome of inappropriate antidiuresis (SIAD): an open-label randomized controlled study (The EFFUSE-FLUID trial)","volume":"76","author":"Krisanapan","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2025.102067_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae386","article-title":"The risk of sodium overcorrections in severe hyponatremia and the utility of desmopressin: a large retrospective study","volume":"18","author":"Lamarche","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.beem.2025.102067_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ana.410130303","article-title":"Central pontine myelinolysis following rapid correction of hyponatremia","volume":"13","author":"Laureno","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.beem.2025.102067_bib23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1172\/JCI117831","article-title":"Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia","volume":"95","author":"Lien","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beem.2025.102067_bib24","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200215","article-title":"Osmotic demyelination syndrome in patients hospitalized with hyponatremia","volume":"2","author":"MacMillan","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.beem.2025.102067_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1212\/WNL.29.2.147","article-title":"Central pontine myelinolysis. Considerations on etiology, diagnosis, and treatment","volume":"29","author":"Messert","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2025.102067_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000493240","article-title":"Hypovolemic hyponatremia","volume":"52","author":"Mohottige","year":"2019","journal-title":"Front Horm Res"},{"key":"10.1016\/j.beem.2025.102067_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ejendo\/lvad108","article-title":"Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study-the TREASURE study","volume":"189","author":"Monnerat","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.102067_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-025-01138-4","article-title":"Hyponatraemia in ageing","author":"Monnerat","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2025.102067_bib29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.120.048739","article-title":"Renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure: the RECEDE-CHF Trial","volume":"142","author":"Mordi","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2025.102067_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/qjmed\/hcg078","article-title":"Solute loss plays a major role in polydipsia-related hyponatraemia of both water drinkers and beer drinkers","volume":"96","author":"Musch","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.beem.2025.102067_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/cen.13966","article-title":"Urea in cancer patients with chronic SIAD-induced hyponatremia: old drug, new evidence","volume":"90","author":"Nervo","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.102067_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ndt\/gfae164","article-title":"Clinical factors associated with hyponatremia correction during treatment with oral urea","volume":"40","author":"Pelouto","year":"2025","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.beem.2025.102067_bib33","doi-asserted-by":"crossref","unstructured":"Peri, Alessandro, Thompson, C.J., Verbalis, J.G., 2019. Disorders of fluid and electrolyte metabolism: focus on hyponatremia.","DOI":"10.1159\/isbn.978-3-318-06383-7"},{"key":"10.1016\/j.beem.2025.102067_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2215\/CJN.03190807","article-title":"DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia","volume":"3","author":"Perianayagam","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2025.102067_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10157-014-1021-y","article-title":"Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?","volume":"19","author":"Pham","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.beem.2025.102067_bib36","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2022050623","article-title":"Treatment effect of the SGLT2 inhibitor empagliflozin on chronic syndrome of inappropriate antidiuresis: results of a randomized, double-blind, placebo-controlled, crossover trial","author":"Refardt","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2025.102067_bib37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2019090944","article-title":"A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis","volume":"31","author":"Refardt","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2025.102067_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000503773","article-title":"Urea for chronic hyponatremia","volume":"49","author":"Rondon-Berrios","year":"2020","journal-title":"Blood Purif"},{"key":"10.1016\/j.beem.2025.102067_bib39","doi-asserted-by":"crossref","first-page":"610","DOI":"10.34067\/KID.0000000000000414","article-title":"Hyponatremia correction rates and mortality: causality or epiphenomenon?","volume":"5","author":"Rondon-Berrios","year":"2024","journal-title":"Kidney 360"},{"key":"10.1016\/j.beem.2025.102067_bib40","article-title":"Tolvaptan, a selective oral vasopressin V 2-receptor antagonist, for hyponatremia","author":"Schrier","year":"2006","journal-title":"A BS TR AC T"},{"key":"10.1016\/j.beem.2025.102067_bib41","doi-asserted-by":"crossref","unstructured":"Seethapathy, H., Zhao, S., Ouyang, T., 2023. Severe Hyponatremia Correction, Mortality, and Central Pontine Myelinolysis. https:\/\/doi.org\/\u300810.1056\/EVIDoa2300107\u3009.","DOI":"10.1056\/EVIDoa2300107"},{"key":"10.1016\/j.beem.2025.102067_bib42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.ajkd.2012.11.032","article-title":"Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia","volume":"61","author":"Sood","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2025.102067_bib43","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2215\/CJN.06990711","article-title":"Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH","volume":"7","author":"Soupart","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2025.102067_bib44","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","author":"Spasovski","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.102067_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-126-1-199701010-00003","article-title":"Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination","volume":"126","author":"Steele","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2025.102067_bib46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ki.2009.251","article-title":"Overcorrection of hyponatremia is a medical emergency","volume":"76","author":"Sterns","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2025.102067_bib47","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1053\/j.ajkd.2010.04.020","article-title":"Treating profound hyponatremia: a strategy for controlled correction","volume":"56","author":"Sterns","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2025.102067_bib48","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJM198606123142402","article-title":"Osmotic demyelination syndrome following correction of hyponatremia","volume":"314","author":"Sterns","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2025.102067_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2215\/CJN.0000000000000244","article-title":"Treatment guidelines for hyponatremia: stay the course","volume":"19","author":"Sterns","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2025.102067_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/advan.00034.2004","article-title":"Cellular volume homeostasis","volume":"28","author":"Strange","year":"2004","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.beem.2025.102067_bib51","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ki.1995.381","article-title":"Swelling-activated organic osmolytic efflux: a new role for anion channels","volume":"48","author":"Strange","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2025.102067_bib52","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1053\/ajkd.1998.v31.pm9631849","article-title":"Beer potomania\u201d in non-beer drinkers: effect of low dietary solute intake","volume":"31","author":"Thaler","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2025.102067_bib53","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2025.102067_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231173327","article-title":"Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD)","volume":"14","author":"Tzoulis","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102067_bib55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cen.12943","article-title":"Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion","volume":"84","author":"Tzoulis","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.102067_bib56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-10-1078","article-title":"Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion","volume":"164","author":"Verbalis","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.102067_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0026-0495(88)90028-5","article-title":"Effect of protein intake and urea on sodium excretion during inappropriate antidiuresis in rats","volume":"37","author":"Verbalis","year":"1988","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2025.102067_bib58","article-title":"Osmotic regulation of plasma vasopressin and oxytocin after sustained hyponatremia","volume":"250","author":"Verbalis","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.beem.2025.102067_bib59","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2025.102067_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2025.102067_bib61","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ki.1991.161","article-title":"Neurological and neuropathological sequelae of correction of chronic hyponatremia","volume":"39","author":"Verbalis","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2025.102067_bib62","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40313","article-title":"Use of urea for the syndrome of inappropriate secretion of antidiuretic hormone: a systematic review","volume":"6","author":"Wendt","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.beem.2025.102067_bib63","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/joim.12532","article-title":"Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis","volume":"280","author":"Winzeler","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.beem.2025.102067_bib64","article-title":"Hyponatremia demystified: integrating physiology to shape clinical practice","author":"Workeneh","year":"2022","journal-title":"Adv Kidney Dis Health"},{"key":"10.1016\/j.beem.2025.102067_bib65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/brain\/102.2.361","article-title":"Pontine and extrapontine myelinolysis","volume":"102","author":"Wright","year":"1979","journal-title":"Brain"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:22:49Z","timestamp":1787152969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X25001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1521690X25001009"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.102067","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of chronic hyponatremia and controversy about osmotic demyelination syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.102067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102067"}}